Exelixis
EXEL
#1696
Rank
S$13.27 B
Marketcap
$46.49
Share price
1.92%
Change (1 day)
46.46%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company